attention us:
Product Catalogue
Contact information
Welcome to call the service hotline



Ophthalmology and Otohinolaryngology

Location>Home>Ophthalmology and Otohinolaryngology>OT005:Retinoblastoma panel


is a malignant tumors from light receptor precursor cells. This kind of disease often occurs in children under 3 years old with the family genetic predisposition, monocular and binocular or successively development at the same time, and is the most common intraocular malignant tumor of infants and young children, rare in adults. Through using the capture technology and a new generation of high-throughput sequencing technology to detect the RB1 gene target area, it can be in early screening out with retinoblastoma disease patient, combining with the history, clinical manifestation. Mygenostics designed the specific gene acquisition scheme for Retinoblastoma to detect the genes mutations by hand in hand with the clinical experts in the field of Retinoblastoma, combined with a new generation of high-throughput sequencing technology and advanced bioinformatics analysis. It can be provide a reliable basis for early diagnosis of diseases in Retinoblastoma according to the individual gene mutation.